Thursday, July 28, 2016

AstraZeneca a takeover target again? CEO not commenting

LONDON, July 28 (Reuters) - AstraZeneca declined to

comment on Thursday on whether the drugmaker could become a

takeover target once more, two years after it saw off a bid from

Pfizer.

Read more

No comments:

Post a Comment